Skip to main content
    G

    GRAIL, LLC (GRAL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $105.60
    -10.29 (-8.88%)

    Market Cap: $5.21B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    GRAIL, LLC (GRAL) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    GRAIL, LLC (GRAL) trades at 29.6x sales and 2.0x book value. Its forward P/E is 1.1x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E1.1x
    Price to sales29.6x
    Price to book2.0x
    PEGN/A
    FCF yield-6.3%

    As of Nov 17, 2026

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About GRAL

    What is GRAL's forward P/E ratio?

    GRAIL, LLC has a forward P/E ratio of 1.1x.

    Is GRAL stock overvalued?

    GNG's valuation label for GRAL is Overvalued.

    What is GRAL's price to sales ratio?

    GRAIL, LLC has a price to sales ratio of 29.6x.